DNAnexus is running a pilot on its genome informatics platform with Google's newly open-sourced DeepVariant variant calling tool.
Google expects its newly released open-source update to DeepVariant to improve the accuracy of variant calling, particularly in plant and animal genomes.
At the Cleveland Clinic Medical Innovation Summit, experts discussed the promise and challenges of genomic and health data, and strategies for taming it.
"It's actually pretty difficult to build an artificially intelligent machine," according to a top Google life scientist, who is more focused on iterative machine learning.
The Colorado Center for Personalized Medicine has allied with the tech giant as it begins to integrate genomic and clinical data.
The former commissioner of the US Food and Drug Administration, Robert Califf, is heading to Alphabet's Verily.
Thomas Insel has left his position at Verily, according to Stat News.
New Scientist wonders whether Verily's Baseline Project will be able to meet its aim of developing a picture of a healthy person.
Verily seeks to expand its Baseline Project to yield a picture of a healthy person, the Verge reports.
CNBC reports that Google's parent company is wooing researchers from the healthcare and life science fields.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.